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Adenosine induces mesangial cell contraction by an A1-type receptor.
Adenosine is known to decrease renal blood flow and glomerular
filtration rate. We have tested the hypothesis that adenosine exerts
contractile effects on mesangial cells. Furthermore, we have studied,
using selective agonists and antagonists for adenosine, which kind of
adenosine receptor, A1 or A2, is mainly implicated in this response. We
also investigated whether calcium is involved in adenosine-induced
mesangial cell contraction. Rat cultured mesangial cells were exposed
to adenosine (lO- to l0 M) and the contraction was measured as
changes in planar cell surface area (PCSA). Adenosine induced a time-
and dose-dependent reduction of PCSA. This reduction in PCSA was
prevented by incubation with the A1 blocker PDI 16,948 but not with the
A2 blocker PDI 15,199. Adenosine-5'-ethylcarboxamide (NECA), an A-,
agonist, did not induce significant changes in PCSA whereas Ne'-
S-l-methyl-2-phenylethyl adenosine (S-PIA). an A1 agonist, induced a
dose-dependent decrease in PCSA. Adenosine-induced mesangial con-
traction was prevented by verapamil or by incubation in a calcium-free
medium. These results suggest that adenosine induces a specific con-
traction of cultured rat mesangial cells that seems to be mediated by its
binding to the adenosine A1-type receptor. This contraction seems to be
dependent on the influx of extracellular calcium.
Adenosine is present in kidney tissue not only in conditions
of ischemia but also in physiological conditions [I]. Intrarenally
produced adenosine has been shown to reduce glomerular
filtration rate (GFR), decrease renal blood flow (RPF) tran-
siently [2, 3], inhibit renin secretion [4, 5] and decrease renal
excretion of sodium and water [61. Although the importance of
adenosine on the intrinsic physiologic control of GFR or RPF is
not fully understood, it has been suggested that adenosine
mediates tubuloglomerular feedback or to be the link between
renal metabolism and GFR regulation 15]. Very little is known
about the exact mechanism by which adenosine affects GFR
and RPF, but it is widely accepted that it increases preglomer-
ular resistance and lowers efferent arteriolar resistance [7, 8].
Furthermore, angiotensin II appears to be essential in the
afferent vasoconstrictor response to adenosine [7].
However, this is not the sole possible mechanism responsible
for the adenosine induced changes in GFR. Glomerular mesan-
gial cells are indirectly connected to smooth muscle cells of
arterioles establishing a functional syncytium, and it is very
likely that a substance that might act on arterioles should also
act on mesangial cells, thus influencing the filtration process [9].
Mesangial cells are able to contract when stimulated with
several substances and vasoactive peptides [10—12] which con-
trol renal function, and this contraction is thought to be related
to changes in the Kf, and thus in GFR [13, 14].
We have previously shown that adenosine contracts isolated
glomeruli [15] and it is quite probable that mesangial cells are
responsible for this contraction. So, we have tested the hypoth-
esis that adenosine has contractile effects on mesangial cells.
Furthermore, we have studied, using selective agonists and
antagonists for adenosine, which kind of adenosine receptor, A1
or A2, [16) is mainly implicated in this response. On the other
hand, we investigated whether calcium, the major messenger
mediating contractile responses [17], is involved in mesangial
cell contraction promoted by adenosine.
Methods
Materials
Adenosine, S-PtA (N6-S- I -methyl-2-phenylethyl adenosine),
N ECA (adenosine-5 '-ethylcarboxamide), TMB-8 [3 ,4,5,trimeth-
oxybenzoic acid 8-(diethyl amino) octyl ester hydrochloride],
collagenase type I A, from clostridium histolyticum and L-
glutamine were purchased from Sigma Chemical Co. (St. Louis,
Missouri, USA). Verapamil was provided by Knoll Iberica,
Madrid. Spain. PD 116,948 (8-ciclopenthyl- I ,3-dipropylxantine)
and PD 155,199 [N-(2-dimethylaminoethyl)-N-methyl-4-(2,3,6,
7-tetrahydro-2 ,6 dioxo- 1 ,3-dipropyl- I H-purin-8-yl)benzenesul-
fonamide] were from Warner-Lambert, Parke Davis, Ann Ar-
bor, Michigan, USA. Penicillin was obtained from Laboratories
Level SA, Barcelona, Spain. Streptomycin sulfate was obtained
from Antibioticos SA, Madrid, Spain. Amphotericin B was
obtained from Squibb Industria Farmaceutica SA, Barcelona,
Spain. RPMI 1640, Flanks balanced salt solution and fetal calf
serum were obtained from Flow Laboratories, Woodcock Hill,
United Kingdom.
Mesangial cell culture
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Renal glomeruli were isolated from Wistar rats weighing 100
to 150 g, maintained on water and standard rat chow ad libitum.
Kidneys were removed under ether anesthesia and glomeruli
isolated by successive mechanical sieving (150 and 50 sm) as
previously described [18]. Isolated glomeruli were treated with
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collagenase, plated in plastic culture flasks and incubated as
previously described [19]. The culture medium consisted of
RPMI 1640 supplemented with 10% fetal calf serum, L-gluta-
mine (1 mM), penicillin (0.66 g/ml). streptomycin sulfate (60
p.glml), amphotericin B (2.5 tg/ml) and buffered with Hepes,
pH 7.2. Culture media was changed every two days. Epithelial
cells grew rapidly whereas mesangial cells grew slowly, with a
peak of mesangial cell density at 18 to 22 days. Studies were
performed on day 21 or 22, at which time epithelial cells were
no longer detected in the culture flasks. The identity of the cells
was confirmed by morphological and functional criteria: under
phase contrast microscopy cells appeared large and stellate. By
transmission electron microscopy the cells contained numerous
bundles of microfilaments, dense patches and elongated nuclei.
Mesangial cells showed histochemical evidence of actin fibers
and they, unlike endothelial cells, did not stain for factor VIII.
In addition, angiotensin converting enzyme activity was nega-
tive in the cultures, and no cells with epithelial or endothelial
morphological characteristics were seen in the cultures. In all
the cultures examined, most of the cells contracted after
incubation with angiotensin II or AVP.
Determination of planar surface area of mesangial cells
Before the experiments, cells were washed from the culture
media and placed in Tris-glucose buffer (Tris 20 mri, NaCI 130
mM, KCI 10 m, sodium acetate 10 m and glucose 5 mM, pH
7.45) containing 2.5 mr'i Ca2 for 30 minutes. Then adenosine or
its agonists (S-PIA or NECA) were added to the media and
incubated for 40 minutes. In the experiments in which antago-
nists of adenosine or calcium antagonists were used, cells were
preincubated in the presence of the antagonist (PDII5,I99,
PD1 16,948, TMB8 or verapamil) for 10 minutes before adding
adenosine. Cells incubated in buffer with the solvent of these
substances were considered as controls.
Direct observation of mesangial cells grown in conventional
plastic culture flasks was carried out at room temperature under
phase contrast with an inverted Olympus photomicroscope.
Serial photographs of the cells were taken before and after
experimental additions. Surface area was determined by a
computer-assisted planimetric technique (Cardio-80, Kontron
Medical, Munich, FRG). Data of mesangial cell contraction are
expressed as mean SEM of three different experiments, with
15 to 20 cells measured per experiment.
Statistical methods
Changes with respect to basal values were analyzed by paired
Student's t-test. Comparisons between means of multiple
groups were analyzed by one-way analysis of variance and
Scheffé's multiple comparisons test. Time course studies were
compared by two-way analysis of variance.
Results
Effects of adenosine on mesangial cell contraction
After 30 minutes of incubation, adenosine decreased mesan-
gial planar cell surface area (PCSA) in a dose-dependent man-
ner. The lowest doses of adenosine tested (10 M and 10 M)
did not produce any change in mesangial superficial area, but in
doses higher than 106 M induced a statistically significant
reduction on PCSA. Figure 1 shows that the addition of
adenosine iO M induced a change in the cell shape, with
decrease in the apparent PCSA of the cells with respect to their
shape before adenosine addition. This contraction was dose-
dependent (Fig. 2) and time-dependent (Fig. 3). Thus, when
mesangial cells were incubated in presence or absence of l0
M adenosine, it was observed that after 10 minutes of incubation
with adenosine, reduction in PCSA was already evident (P <
0.001), while no change was observed in control cells.
Effects of adenosine agonists S-PIA (A,) and NECA (A2)
S-PIA, an agonist for type A1 adenosine receptors, had a very
similar effect to that of adenosine on mesangial cell contraction.
While the lowest doses of S-PIA (l0 and 106 M)did not have
any effect, concentrations higher than l0_6 M diminished PCSA
(Fig. 4).
On the contrary, NECA, an A, agonist, did not show any
dose-dependent response and none of the concentrations tested(l0 to l0 M) induced changes in PCSA.
Effects of the antagonists PDII5,199 and PDII6,199
Preincubation of cells with PDI 16,948 (10—6 M), an A1 highly-
selective antagonist ligand, completely inhibited adenosine-in-
duced mesangial cell contraction (Fig. 5). However PDI 15,199
(l0 M), an antagonist ligand of high affinity for A2 adenosine
receptors, was unable to modify adenosine l0 M induced
response. When both A1 and A2 antagonists were used, l0 M
adenosine did not contract mesangial cells. Preincubations with
either antagonist alone did not significantly modify mesangial
cell area after 40 minutes (91 5.3% and 107 4.7% of initial
surface area for A1 and A, antagonists, respectively).
Effects of the calcium antagonists verapamil and TMB8
Figure 6 shows that preincubation with verapamil (10 M)
prevented l0 M adenosine induced contraction, while TMB8(l0 M) was not able to prevent it. In addition, l0 M
adenosine did not reduce mesangial area when cells were
incubated in a calcium free medium. Preincubation with vera-
pamil or TMB8 alone did not modify planar surface area (91.7
4.7% of initial surface area after 40 mm in control cells vs. 90
2.7% or 91.7 4.6% in verapamil or TMB8 pretreated cells).
Discussion
Adenosine has been proved to decrease GFR and RBF by
modifying arteriolar efferent and afferent resistance [2, 7, 20]. A
transient increase of preglomerular vessel resistance appears to
explain adenosine-mediated renal transient vasoconstriction.
Persistent decrease in GFR which occurs in spite of an increase
of RPF after 20 to 30 minutes of adenosine infusion is explained,
in addition, by its vasorelaxant effects on efferent arterioles [7].
Here we propose mesangial cell contraction as another mech-
anism by which adenosine could be able to decrease GFR
independently of RPF changes.
Our results demonstrate that adenosine induces a dose- and
time-dependent reduction of rat mesangial cell surface area.
Mesangial cell area reduction is generally considered as con-
traction [21, 22, 12]. Adenosine induced reduction of PCSA
seems to be mediated by the binding of adenosine to a specific
receptor since it can be inhibited by a selective antagonist of A1
adenosine receptor (PDI 16,948). The ability of mesangial cells
to contract as a specific response [23] to distinct agonists is
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Fig. 1. Effect of lO Madenosine on the shape of cultured nzesangial cells. Figure shows the same photographic field before (A)and 30 mm after
adenosine (B). Note the change in cell shape and the decrease in planar cell surface area.
widely considered as a mechanism of reduction of the K1 [12,
24] by which mesangial cells regulate GFR [13, 14, 241. Thus,
adenosine would induce a sustained contraction of these cells
that could be responsible, at least in part, for the reduction in
GFR induced by adenosine. In agreement with these results we
have previously shown that adenosine reduces cross sectional
area of isolated glomeruli 1151, and probably mesangial cells are
the major element which accounts for this effect. To our
knowledge, the in vivo effect of adenosine on K1 has been
reported only by Oswald, Speilman and Knox [20] and they did
not find any change in K. However these studies were per-
formed in dogs which probably had an activated renin-angio-
tensin system because of the surgical stress associated with the
micropuncture studies, and the high levels of angiotensin,
acting directly on the K1, could mask the effect of adenosine on
K1. Moreover, in vivo and in vitro experiments are not easily
comparable. Renal feedback mechanisms are completely intact
in micropuncture experiments whereas only local feedback
mechanisms remain active in cultured mesangial cells. In other
words, in the micropuncture studies, not only the effect of the
injected agonists are observed, but also the effects of other
vasoactive systems which is modified by the substance tested.
In the case of adenosine, it presumably modifies catecholamine
release, renin-angiotensin system activation and prostanoid
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Fig. 2. Effect of different doses of adenosine (l0- to /0 M) on the
reduction of PCSA after 40 minutes of incubation. PCSA at minute 40
is expressed as percentage of initial PCSA. Data are mean SEM.
* Statistically significant differences (P < 0.05) with respect to cells
incubated in control conditions (C); ** statistically significant differ-
ences (P < 0.01) with respect to cells incubated in control conditions.
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Time, minutes
Fig. 3. Tune-course of the effect ofadenosine (circles) on the reduction
ofmesangialPCSA expressed asa percentage cf initial PCSA. Data are
mean SEM. * Statistically significant differences (P < 0.01) with
respect to cells incubated in control conditions (triangles).
Log lAgonistl, M
Fig. 4. Dose-triangle of the A2 agonist NECA (open circles), and the
A, agonist S-PIA (filled circles) on the reduction of mesangial PCSA
after 40 mm of incubation. Data are mean SEM. PCSA at the minute
40 is expressed as a percentage of initial PCSA. * Statistically signifi-
cant differences (P < 0.01) with respect to cells incubated in control
conditions (C). The dose-response curve of NECA is statistically
different (P < 0.01) from that of 5-PIA.
Control ADO iO PD 115,199 PD 116,948 PD 115,199 +
+ + PD116,948+ADO io- ADO i0- ADO i0
Fig. 5. Effect of the antagonists of adenosine on the reduction of
inesangial PCSA inducd b' adenosine io- M. Cells were preincubated
with the antagonist A, (PDII6,948) or A (PDll5,l19) or both for 10
minutes before adding adenosine. PCSA at the minute 40 of incubation
with adenosine is expressed as a percentage of initial PCSA. Data are
mean SEM. * Statistically significant differences (P < 0.01) with
respect to cells incubated in control conditions; * statistically signifi-






















those that are active contracting mesangial cells "in vitro". We
do not have a clear explanation for this discrepancy, but it is
possible that differences in temperature could be a reason. The
in vitro experiments performed at room temperature (22°C) and
in vivo studies performed at 37°C could be a temperature
a a difference influencing both the kinetics of adenosine binding to
C 7 —6 5 ' its receptors, and the intracellular processes leading to cell
contraction. In addition, phenotypical characteristics of the
cultured mesangial cells could differ from those of cells in vivo
in the number of membrane receptors, its affinity for adenosine
or the ability to contract. In fact, it has been reported that after
multiple culture passages, the cells lose membrane receptors for
angiotensin Il [25]. Finally, pericellular adenosine concentra-
tion in the in vivo studies are not known, and perhaps it could
be similar to those in which we found a contractile response.
measured by the micropuncture techniques. In vitro experi-
ments can clarify these mechanisms.
As mentioned above, adenosine contracts mesangial cells in a
concentration dependent fashion. Although the higher concen-
tration tested (10 M) produced the maximal contraction, these
effects were already evident at a dose of lO M. However, we
are concerned about the dissociation existing between the
concentrations of adenosine which exerts its effects in vivo and
Two classes of external receptors for adenosine, namely A,
and A, adenosine receptors, have been recognized [6, 16, 26,
27]. In many cell types A, receptors couple to adenylate cyclase
in an inhibitory manner [16] and A2 receptors couple to adenyl-
ate cyclase in a stimulatory way [28, 29]. The presence of A,
and A, sites in the kidney has been shown by several investi-
gators [26—32]. Autoradiographic visualization of adenosine A,
receptors in human kidney shows a periglomerular localization
of these receptors [31]. Glomeruli have both receptors: A,,
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Fig. 6. Effect of the calcium antagonists on the reduction of mesangial
PCSA induced by adenosine io- M. PCSA at each time is expressed as
a percentage of initial PCSA. Cells were pretreated with verapamil or
TMB8 before adding adenosine. Symbols are: (A) control cells; (LI)
verapamil + adenosine; (0) adenosine + calcium-free medium: (•)
TMB8 + adenosine; (I) adenosine alone. The curves of adenosine and
TMB8 + adenosine treated cells were statistically different (P < 0.01)
from that of control cells. The curves of adenosine + calcium-free
medium and verapamil + adenosine were statistically different (P <
0.01) from that of adenosine alone.
demonstrated by binding studies, and A,, functionally identified
[321. Our results suggest that adenosine-induced mesangial cell
contraction is mediated by an A1 adenosine receptor for the
following reasons: The Al agonist S-PIA reproduced the dose-
dependent adenosine response, whereas the more potent A,
agonist NECA did not induce mesangial cell contraction. A1
selective antagonist PD 116,948 abolished the response elicited
by ADO, in contrast to the A2 antagonist PD 115,199, which did
not modify it. Although the existence of an A1 receptor type
involved in mesangial contraction can be deduced from these
data, the characterization of this receptor by binding studies
would be necessary for direct evidence.
The lack of a role for A2 receptors in adenosine induced
contraction of glomerular mesangial cells is supported by the
fact that NECA infusion did not modify GFR in anesthetized
rats [8]. In addition, NECA increased GFR in perfused kidneys
by relaxing the efferent arteriole [33]. Although NECA has
some affinity for A1 receptors, its physiological effects seem to
be related to relaxation and cAMP increments by acting on A2
receptors. Another result supporting the lack of involvement of
A2 receptors in mesangial contraction is the lack of effect of the
A, antagonist PD1I5,l99 to prevent adenosine-induced mesan-
gial cell contraction.
Our results also suggest that adenosine induced contraction
of mesangial cells is dependent on the influx of calcium from
extracellular medium since it did not occur in a calcium-free
medium or in the presence of the calcium entry blocker,
verapamil. In agreement with these results, dogs pretreated
with verapamil showed neither the vasoconstrictor effect of
adenosine nor the adenosine induced decrease in GFR [4, 341.
In addition, verapamil inhibited the contraction of rat isolated
glomeruli induced by adenosine [15]. An alternative explanation
for the effect of verapamil on the response of mesangial cells to
adenosine would be that the calcium antagonist inhibits the
binding of adenosine to its receptor as suggested by Marangos,
Deckert and Bisserbe [35]; however, the non-dihydropyridine
calcium channel blockers such as verapamil have a very low
effect on modifying the binding of adenosine to its receptors
[35]. We have also tested the possible role of the intracellular
calcium pools in the adenosine induced contraction. For that
purpose, we used a relatively selective blocker of the calcium
release from the intracellular poo1s, TMB-8 [36]. Pretreatment
with this compound did not modify the contractile response of
contraction of mesangial cells as previously reported [12] and
may be related to a decrease in the Kand therefore in the GFR.
Thus, the reduction in GFR after adenosine infusion may be
mediated, at least in part, by its effects on mesangial cells.
However, in the present study, the adenosine induced contrac-
tion has been observed only at pharmacological concentrations,
thus rendering the direct application of these results difficult to
the physiological conditions. This contractile effect seems to be
mediated by a specific A1 adenosine receptor. In addition,
calcium entry is necessary for the decrease in PCSA induced by
adenosine. However, additional experiments are necessary for
the complete elucidation of the cellular mechanism of action on
mesangial cells.
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